Select Your Region
- Manufacturer: Evonik Corporation
- Product Line: RESOMER® Polymers
- Product: RESOMER® RG Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
RESOMER® RG 756 S
RESOMER® RG 756 S is an advanced controlled drug release agent form Evonik containing a 75:25 D,L-lactide to Glycolide ratio with a degredation rate of 6 months. It is especially recommended for parenteral drug products and medical systems.
Quantity
Documents
Specifications
Physical state: Solid
Form: Powder granules
Color: White to off-white
Inherent viscosity (dl/g): 0.71─1.0
Degradation time: <6 months
CAS No. 26780-50-7
Primary Chemistry:
Poly(D,L-lactide-co-glycolide)
- Manufacturer: Evonik Corporation
- Product Line: RESOMER® Polymers
- Product: RESOMER® RG Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
Manufacturer
Product Line
Product
Industries
Authorized Countries
Canada
United States
Overview
RESOMER® RG 756 S is a specialized lactide copolymer
Specifications
Physical state: Solid
Form: Powder granules
Color: White to off-white
Inherent viscosity (dl/g): 0.71─1.0
Degradation time: <6 months
CAS No. 26780-50-7
Primary Chemistry:
Poly(D,L-lactide-co-glycolide)
Features & Benefits
- Solvent-purified co-polymer
- 75:25 D,L-lactide:Glycolide ratio
- Alkyl ester terminated
- 3-month degradation period
- Bioabsorbable
- Biodegradable
- Processed by injection molding
- Completely metabolized by the body
- Ideal for terminal sterilization
- Suitable for use with small molecules, peptides, proteins, and other substances
Applications
Controlled release applications
Microparticles and drug-loaded implants
Long acting medication delivery formulations
Related Applications
Pharmaceuticals
Related Functions
Pharmaceuticals
ChemPoint is here to help
Are you in the correct region?
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - United States
